
Some of the deal activity among medical device makers and pharmaceutical companies can be explained by the belief that gaining scale and becoming a leading provider is essential for effectively negotiating business with hospitals and insurers, according to The New York Times. Some of the impetus to consolidate can also be explained by the desire to acquire emerging product lines and biotech firms to supplement the declining sales of older products.

http://www.healthleadersmedia.com/finance/strategic-planning-initiatives-healthcare-systems

At CHI, there are several key elements to “closing the loop on strategic planning with financial planning,” DiCola says, including assessing the capital requirements linked to strategic objectives, allocating capacities, making sure the organization has a multi-year financial plan aligned with its strategic plan, and remaining open to course corrections. “Strategic planning is not set in stone—it’s a living thing.”
